Abstract:Multifactorial interactions involved pro-inflammatory microenvironment plays a crucial role in ulcerative colitis initiation and progression. Oral nanozymes hold great promise in ameliorating inflammation attributing to their enzyme mimesis-mediated oxidative stress regulation capabilities. However, the development of biocompatible, gastrointestinal well-tolerant, and multi-enzyme mimetic antioxidant nanomedicine is highly desirable but challenging. Here, inspired by natural occurring fungal allomelanin, intrinsically bioactive allomelanin-like nanomedicine (alloMel) were fabricated as a safe and effective formulation for re-educating the intestinal pro-inflammatory microenvironment in colitis. The as-preapared alloMel possessed satisfactory biocompatibility, hydrogen peroxide-triggered decomposition behavior, broad-spectrum free radical scavenging capacities and specific targeting ability toward the colitis lesions. More importantly, alloMel exhibited favorable tolerance against the harsh gastrointestinal environment, evidenced by structural and property stability assay in simulated gastric fluid and simulated intestinal fluid. Following oral administration into dextran sulfate sodium-induced acute colitis mice, alloMel exhibited superior therapeutic efficacy than that of 2.5-fold dose of the first-line drug 5-aminosalicylic acid, evidenced by reversed body weight loss, decreased disease activity index, restrained colon length shortening, and mitigatory histopathological abnormalities. Mechanistically, alloMel ameliorated the self-perpetuating pro-inflammatory microenvironment by combined actions including alleviating oxidative stress, reducing the production of pro-inflammatory cytokines, restraining inflammatory cell infiltration, switching macrophage phenotype, and restoring intestinal barrier integrity. Molecularly, alloMel could inhibit the TLR4/MyD88/NF-кB signaling pathway. In conclusion, the as-reported alloMel with favorable gastrointestinal tolerance and well-elucidated mechanisms represents a potential translational nanomedicine against colitis and oxidative stress-associated other gastrointestinal inflammatory disorders.

Antioxidative Single Atomic Nanocatalysts Facilitate Orally Administered Probiotic Inulin Gels for Acute Colitis Amelioration

Optimization of a gelatin/carboxymethylcellulose-based probiotic microcapsule and its application in preventing dextran sodium sulfate-induced colitis in mice.

Microfluidics-Derived Microparticles with Prebiotics and Probiotics for Enhanced in Situ Colonization and Immunoregulation of Colitis.

Carboxymethyl Konjac Glucomannan-Chitosan Complex Nanogels Stabilized Emulsions Incorporated into Alginate As Microcapsule Matrix for Intestinal-Targeted Delivery of Probiotics: in Vivo and in Vitro Studies.

Oral delivery of sodium alginate/chitosan bilayer microgels loaded with Lactobacillus rhamnosus GG for targeted therapy of ulcerative colitis

Programmable probiotics modulate inflammation and gut microbiota for inflammatory bowel disease treatment after effective oral delivery

Probiotics Armed with In Situ Mineralized Nanocatalysts and Targeted Biocoatings for Multipronged Treatment of Inflammatory Bowel Disease

Nanoprobiotics for Remolding the Pro-inflammatory Microenvironment and Microbiome in the Treatment of Colitis

Intracellular hydrogelation of macrophage conjugated probiotics for hitchhiking delivery and combined treatment of colitis

Intracellularly Gelated Macrophages Loaded with Probiotics for Therapy of Colitis

Oral-administered Allomelanin-Like Nanomedicine with Multi-Enzyme Mimesis and Favorable Gastrointestinal Tolerance for Amelioration of Acute Colitis

Orally Administrated Inflamed Colon-Targeted Nanotherapeutics for Inflammatory Bowel Disease Treatment by Oxidative Stress Level Modulation in Colitis

Responsively Degradable Nanoarmor-Assisted Super Resistance and Stable Colonization of Probiotics for Enhanced Inflammation-Targeted Delivery

Probiotic‐inspired nanomedicine restores intestinal homeostasis in colitis by regulating redox balance, immune responses, and the gut microbiome

Poly‐γ‐Glutamic Acid Microgel‐Encapsulated Probiotics with Gastric Acid Resistance and Smart Inflammatory Factor Targeted Delivery Performance to Ameliorate Colitis

Closed-loop theranostic microgels for immune microenvironment modulation and microbiota remodeling in ulcerative colitis

An Oral Nano-Antioxidant for Targeted Treatment of Inflammatory Bowel Disease by Regulating Macrophage Polarization and Inhibiting Ferroptosis of Intestinal Cells

Modified Prebiotic-Based "Shield" Armed Probiotics with Enhanced Resistance of Gastrointestinal Stresses and Prolonged Intestinal Retention for Synergistic Alleviation of Colitis

Bioorthogonal conjugation and responsive nanocoating of probiotics for inflammatory bowel disease

A Gas Therapy Strategy for Intestinal Flora Regulation and Colitis Treatment by Nanogel‐based Multistage NO Delivery Microcapsules

Orally administered titanium carbide nanosheets as anti-inflammatory therapy for colitis